The University of Cologne is a university in Cologne, Germany. It was established in the year 1388 and is one of the most prestigious and research intensive universities in Germany. It was the sixth university to be established in Central Europe. It closed in 1798 before being re-established in 1919.

During the past decade, University of Cologne conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Cologne" #1 sponsor was "University of Cologne" with 26 trials, followed by "Radboud University Medical Center" with 3 trials sponsored, "Rockefeller University" with 3 trials sponsored, "Association of Urologic Oncology (AUO)" with 1 trials sponsored and "Baxter Healthcare Corporation" with 1 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cologne" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "University of Cologne" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 2 trials as a collaborator and "Charite University, Berlin, Germany" with 2 trials as a collaborator. Other collaborators include 92 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "University of Cologne" are "Multiple Myeloma" (4 trials), "HIV Infections" (3 trials), "HIV" (2 trials), "Healthy" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "University of Cologne" in a lesser frequency.

Most popular intervention types in "University of Cologne" are "Drug" (30 trials), "Other" (6 trials), "Device" (5 trials), "Procedure" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Rituximab" (4 trials), "Cyclophosphamide" (3 trials), "Prednisone" (3 trials) and "Bleomycin" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Cologne" are 54 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Cologne". 1 are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in University of Cologne, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Cologne, 5 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".